Michael M. Morgen

Polymeric Nanoparticles for Increased Oral Bioavailability and Rapid Absorption Using Celecoxib as a Model of a Low-Solubility, High-Permeability Drug

Michael M. Morgen, Corey Bloom, Ron Beyerinck et al. · Pharmaceutical Research · 2011 · 147 citations · Full text

Impact of Drug-Rich Colloids of Itraconazole and HPMCAS on Membrane Flux <i>in Vitro</i> and Oral Bioavailability in Rats

Aaron M. Stewart, Timothy J. Brodeur, Aaron K. Goodwin et al. · Molecular Pharmaceutics · 2017 · 116 citations · Full text

Pharmaceutical Science, Oral Bioavailability, Engineering +18

Nanoparticles for Improved Local Retention after Intra-Articular Injection into the Knee Joint

Michael M. Morgen, David Tung, Britton Boras et al. · Pharmaceutical Research · 2012 · 81 citations · Full text

Development of a Biorelevant, Material-Sparing Membrane Flux Test for Rapid Screening of Bioavailability-Enhancing Drug Product Formulations

Aaron M. Stewart, Deanna M. Mudie, Michael M. Morgen et al. · Molecular Pharmaceutics · 2017 · 62 citations

Pharmaceutical Science, Dissolution Rate, Membrane Diffusion +12

Lipophilic salts of poorly soluble compounds to enable high-dose lipidic SEDDS formulations in drug discovery

Michael M. Morgen, Ajay Saxena, Xueqing Chen et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2017 · 54 citations · Full text

Pharmaceutical Science, Pharmacotherapy, Drug Solubility +18